Gain Therapeutics
GANX
GANX
14 hedge funds and large institutions have $6.65M invested in Gain Therapeutics in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $8.95M → $6.65M (-$2.3M)
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$491K | |
| 2 | +$405K | |
| 3 | +$221K | |
| 4 |
V
Veritable
Wilmington,
Delaware
|
+$187K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$20K |